These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19808419)

  • 1. Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development.
    Tan HL; van der Wal AC; Campian ME; Kruyswijk HH; ten Hove Jansen B; van Doorn DJ; Oskam HJ; Becker AE; Wilde AA
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):276-81. PubMed ID: 19808419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiologic findings and high frequency catheter ablation in atriofascicular and nodoventricular pathways ("Mahaim bundles")].
    Kottkamp H; Chen X; Hindricks G; Willems S; Haverkamp W; Wichter T; Breithardt G; Borggrefe M
    Z Kardiol; 1995; 84 Suppl 2():153-62. PubMed ID: 7571779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
    Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
    Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
    Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
    J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare connection: fasciculoventricular pathway in PRKAG2 disease.
    Govindan M; Ward D; Behr E
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):329-32. PubMed ID: 19732236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
    Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
    J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen.
    Folmes KD; Chan AY; Koonen DP; Pulinilkunnil TC; Baczkó I; Hunter BE; Thorn S; Allard MF; Roberts R; Gollob MH; Light PE; Dyck JR
    Circ Cardiovasc Genet; 2009 Oct; 2(5):457-66. PubMed ID: 20031621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial pseudo-Wolff-Parkinson-White syndrome.
    Sternick EB; Oliva A; Magalhães LP; Gerken LM; Hong K; Santana O; Brugada P; Brugada J; Brugada R
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):724-32. PubMed ID: 16836667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
    Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
    Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The electrocardiogram during sinus rhythm and tachycardia in patients with Mahaim fibers: the importance of an "rS" pattern in lead III.
    Sternick EB; Timmermans C; Sosa E; Cruz FE; Rodriguez LM; Fagundes MA; Gerken LM; Wellens HJ
    J Am Coll Cardiol; 2004 Oct; 44(8):1626-35. PubMed ID: 15489095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
    Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
    Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure.
    Liu Y; Bai R; Wang L; Zhang C; Zhao R; Wan D; Chen X; Caceres G; Barr D; Barajas-Martinez H; Antzelevitch C; Hu D
    PLoS One; 2013; 8(5):e64603. PubMed ID: 23741347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A/C gene.
    Otomo J; Kure S; Shiba T; Karibe A; Shinozaki T; Yagi T; Naganuma H; Tezuka F; Miura M; Ito M; Watanabe J; Matsubara Y; Shirato K
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):137-45. PubMed ID: 15720451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical course and risk in patients with pseudo-Mahaim fibers.
    Szumowski L; Bodalski R; Jedynak Z; Szufladowicz E; Kepski R; Derejko P; Urbanek P; Michalak E; Orczykowski M; Zakrzewska J; Przybylski A; Walczak F
    Cardiol J; 2008; 15(4):365-70. PubMed ID: 18698546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare forms of preexcitation: a case study and brief overview of familial forms of preexcitation.
    Koneru JN; Wood MA; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):e82-7. PubMed ID: 22895604
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis.
    Lopez-Sainz A; Dominguez F; Lopes LR; Ochoa JP; Barriales-Villa R; Climent V; Linschoten M; Tiron C; Chiriatti C; Marques N; Rasmussen TB; Espinosa MÁ; Beinart R; Quarta G; Cesar S; Field E; Garcia-Pinilla JM; Bilinska Z; Muir AR; Roberts AM; Santas E; Zorio E; Peña-Peña ML; Navarro M; Fernandez A; Palomino-Doza J; Azevedo O; Lorenzini M; García-Álvarez MI; Bento D; Jensen MK; Méndez I; Pezzoli L; Sarquella-Brugada G; Campuzano O; Gonzalez-Lopez E; Mogensen J; Kaski JP; Arad M; Brugada R; Asselbergs FW; Monserrat L; Olivotto I; Elliott PM; Garcia-Pavia P;
    J Am Coll Cardiol; 2020 Jul; 76(2):186-197. PubMed ID: 32646569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Accessory atrioventricular pathways with decremental conduction (Mahaim connections). 2 case reports].
    Fiala M; Heinc P; Lukl J
    Vnitr Lek; 1997 Oct; 43(10):663-71. PubMed ID: 9601881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short atrioventricular Mahaim fibers: observations on their clinical, electrocardiographic, and electrophysiologic profile.
    Sternick EB; Fagundes ML; Cruz FE; Timmermans C; Sosa EA; Rodriguez LM; Gerken LM; Scanavacca MI; Wellens HJ
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):127-34. PubMed ID: 15720449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
    Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
    Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.